Cadent Capital Advisors, LLC Bio Techne Corp Transaction History

Cadent Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$322.67 - $449.65 $170,369 - $237,415	-528 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$456.15 - $525.06 $8,666 - $9,976	-19 Reduced 3.47%	528 $273,000
Q1 2021 May 12, 2021	SELL	$314.62 - $411.0 $33,035 - $43,155	-105 Reduced 16.1%	547 $209,000
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $160,978 - $209,859	652 New	652 $207,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Cadent Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cadent Capital Advisors, LLC with notifications on news.